OPKO Health is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and commercialization expertise and its novel and proprietary technologies. The Company intends to leverage its global commercialization expertise to pursue acquisitions of commercial businesses that will both drive growth and provide geographically diverse sales and distribution opportunities.
Type
Public
HQ
Miami, US
Founded
2007
Size (employees)
6,041 (est)
Website
opko.com
Opko Health was founded in 2007 and is headquartered in Miami, US
Report incorrect company information

Key People/Management at Opko Health

Phillip Frost

Phillip Frost

CEO
Jane Hsiao

Jane Hsiao

CTO

Opko Health Office Locations

Opko Health has offices in Miami and Woburn
Miami, US (HQ)
4400 Biscayne Blvd
Show all (2)
Report incorrect company information

Opko Health Financials and Metrics

Opko Health Financials

Opko Health's revenue was reported to be $1.07 b in FY, 2017
USD

Revenue (Q1, 2018)

254.9 m

Net income (Q1, 2018)

(43.1 m)

EBIT (Q1, 2018)

(42.6 m)

Market capitalization (23-May-2018)

2 b

Closing share price (23-May-2018)

3.7

Cash (31-Mar-2018)

99.9 m
Opko Health's current market capitalization is $2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

96.5 m91.1 m491.7 m1.2 b1.1 b

Revenue growth, %

(6%)440%148%

General and administrative expense

490.9 m521 m

R&D expense

111.2 m125.2 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

20.6 m22.3 m23.5 m19.8 m30.1 m42.4 m143 m291 m357.1 m298 m296.1 m314.2 m254.9 m

General and administrative expense

13.6 m13.8 m14.9 m14 m17.4 m20.9 m55.2 m128 m117.5 m124.8 m136.7 m128.3 m91.5 m

R&D expense

11.1 m21 m16.2 m20.5 m25.5 m29.6 m18.9 m27.8 m31.3 m24.4 m26 m32.6 m32.9 m

Operating expense total

39.7 m52.6 m58.4 m68 m87 m67.8 m151.3 m318.6 m328.8 m321.7 m337.8 m340.7 m297.5 m
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Cash

185.8 m193.6 m168.7 m91.5 m

Accounts Receivable

19.8 m193.9 m220.3 m165.5 m

Inventories

19.1 m26.9 m47.2 m49.3 m

Current Assets

242.7 m454.1 m483.6 m343.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

155.8 m156.4 m134 m118.3 m348.2 m221.2 m212.1 m175 m156 m144.6 m131.1 m130.5 m99.9 m

Accounts Receivable

21.4 m19.7 m23.1 m21.2 m19.1 m27 m189.7 m204.5 m213.4 m223.8 m238.9 m251.7 m158.6 m

Inventories

19.5 m18.9 m18.3 m16.7 m18.3 m20.5 m40.7 m40.6 m42 m43.2 m47.5 m48.3 m49.8 m

Current Assets

241.3 m205.3 m183 m163.1 m394 m278.3 m517.4 m453.5 m505.6 m502.1 m459.9 m472.5 m349.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(117.3 m)(174.6 m)(31.4 m)(25.1 m)(308.9 m)

Depreciation and Amortization

11.1 m14.9 m28 m64.4 m102.1 m

Inventories

19.1 m3.2 m(4.4 m)

Accounts Payable

13.4 m(3.9 m)(18.1 m)(19.8 m)20.2 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(60.8 m)(45.1 m)(26.1 m)(50 m)(118 m)(43.2 m)128.2 m(12 m)15.5 m(15 m)(31 m)(43.1 m)

Depreciation and Amortization

2.8 m2.7 m2.7 m3.2 m8.1 m13.4 m15.8 m18.1 m17.9 m24.8 m

Inventories

40.6 m

Accounts Payable

10 m8.8 m10.5 m16 m78 m73.4 m61.1 m58.5 m74.6 m(10.2 m)
USDY, 2018

Financial Leverage

1.4 x
Show all financial metrics
Report incorrect company information